DXC Technology Aktie
WKN DE: A2DM8U / ISIN: US23355L1061
20.07.2020 22:42:26
|
DXC Technology To Sell Its Healthcare Software Provider Business - Quick Facts
(RTTNews) - DXC Technology (DXC) has agreed to sell the company's healthcare software provider business to Dedalus Group for $525 million. The deal is anticipated to close by March 2021. The company noted that the sale is not subject to any financing conditions or shareholder approvals.
"The sale of our healthcare provider software business to Dedalus is consistent with our strategy of focusing on the Enterprise Technology Stack and rationalizing our portfolio," said Mike Salvino, CEO, DXC Technology.
Dedalus Group is a leading healthcare and diagnostic software provider in Europe.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DXC Technologymehr Nachrichten
Analysen zu DXC Technologymehr Analysen
Aktien in diesem Artikel
DXC Technology | 13,57 | 4,83% |
|